N-Alkoxyphenylhydroxynaphthalenecarboxamides and Their Antimycobacterial Activity

A series of nineteen N-(alkoxyphenyl)-2-hydroxynaphthalene-1-carboxamides and a series of their nineteen positional isomers N-(alkoxyphenyl)-1-hydroxynaphthalene-2-carboxamides were prepared and characterized. Primary in vitro screening of all the synthesized compounds was performed against Mycobact...

Full description

Bibliographic Details
Main Authors: Tomas Gonec, Sarka Pospisilova, Tereza Kauerova, Jiri Kos, Jana Dohanosova, Michal Oravec, Peter Kollar, Aidan Coffey, Tibor Liptaj, Alois Cizek, Josef Jampilek
Format: Article
Language:English
Published: MDPI AG 2016-08-01
Series:Molecules
Subjects:
Online Access:http://www.mdpi.com/1420-3049/21/8/1068
id doaj-dad29cb37957460dbd8842a6ec8ed858
record_format Article
spelling doaj-dad29cb37957460dbd8842a6ec8ed8582020-11-24T22:48:05ZengMDPI AGMolecules1420-30492016-08-01218106810.3390/molecules21081068molecules21081068N-Alkoxyphenylhydroxynaphthalenecarboxamides and Their Antimycobacterial ActivityTomas Gonec0Sarka Pospisilova1Tereza Kauerova2Jiri Kos3Jana Dohanosova4Michal Oravec5Peter Kollar6Aidan Coffey7Tibor Liptaj8Alois Cizek9Josef Jampilek10Department of Chemical Drugs, Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences, Palackeho 1, Brno 61242, Czech RepublicDepartment of Infectious Diseases and Microbiology, Faculty of Veterinary Medicine, University of Veterinary and Pharmaceutical Sciences, Palackeho 1, Brno 61242, Czech RepublicDepartment of Human Pharmacology and Toxicology, Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences, Palackeho 1, Brno 61242, Czech RepublicDepartment of Chemical Drugs, Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences, Palackeho 1, Brno 61242, Czech RepublicCentral Laboratories, Faculty of Chemical and Food Technology, Slovak University of Technology in Bratislava, Radlinskeho 9, Bratislava 81237, SlovakiaGlobal Change Research Institute CAS, Belidla 986/4a, Brno 60300, Czech RepublicDepartment of Human Pharmacology and Toxicology, Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences, Palackeho 1, Brno 61242, Czech RepublicDepartment of Biological Sciences, Cork Institute of Technology, Bishopstown, Cork, IrelandCentral Laboratories, Faculty of Chemical and Food Technology, Slovak University of Technology in Bratislava, Radlinskeho 9, Bratislava 81237, SlovakiaDepartment of Infectious Diseases and Microbiology, Faculty of Veterinary Medicine, University of Veterinary and Pharmaceutical Sciences, Palackeho 1, Brno 61242, Czech RepublicDepartment of Pharmaceutical Chemistry, Faculty of Pharmacy, Comenius University, Odbojarov 10, Bratislava 83232, SlovakiaA series of nineteen N-(alkoxyphenyl)-2-hydroxynaphthalene-1-carboxamides and a series of their nineteen positional isomers N-(alkoxyphenyl)-1-hydroxynaphthalene-2-carboxamides were prepared and characterized. Primary in vitro screening of all the synthesized compounds was performed against Mycobacterium tuberculosis H37Ra, M. kansasii and M. smegmatis. Screening of the cytotoxicity of the compounds was performed using human monocytic leukemia THP-1 cells. Some of the tested compounds showed antimycobacterial activity comparable with or higher than that of rifampicin. For example, 2-hydroxy-N-(4-propoxyphenyl)-naphthalene-1-carboxamide showed the highest activity (MIC = 12 µM) against M. tuberculosis with insignificant cytotoxicity. N-[3-(But-2-yloxy)phenyl]- and N-[4-(but-2-yloxy)phenyl]-2-hydroxy-naphthalene-1-carboxamide demonstrated high activity against all tested mycobacterial strains and insignificant cytotoxicity. N-(Alkoxyphenyl)-1-hydroxynaphthalene-2-carboxamides demonstrated rather high effect against M. smegmatis and M. kansasii and strong antiproliferative effect against the human THP-1 cell line. Lipophilicity was found as the main physicochemical parameter influencing the activity. A significant decrease of mycobacterial cell metabolism (viability of M. tuberculosis H37Ra) was observed using MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide) assay. Structure-activity relationships are discussed.http://www.mdpi.com/1420-3049/21/8/1068hydroxynaphthalenecarboxamidesin vitro antimycobacterial activityMTT assaylipophilicitystructure-activity relationships
collection DOAJ
language English
format Article
sources DOAJ
author Tomas Gonec
Sarka Pospisilova
Tereza Kauerova
Jiri Kos
Jana Dohanosova
Michal Oravec
Peter Kollar
Aidan Coffey
Tibor Liptaj
Alois Cizek
Josef Jampilek
spellingShingle Tomas Gonec
Sarka Pospisilova
Tereza Kauerova
Jiri Kos
Jana Dohanosova
Michal Oravec
Peter Kollar
Aidan Coffey
Tibor Liptaj
Alois Cizek
Josef Jampilek
N-Alkoxyphenylhydroxynaphthalenecarboxamides and Their Antimycobacterial Activity
Molecules
hydroxynaphthalenecarboxamides
in vitro antimycobacterial activity
MTT assay
lipophilicity
structure-activity relationships
author_facet Tomas Gonec
Sarka Pospisilova
Tereza Kauerova
Jiri Kos
Jana Dohanosova
Michal Oravec
Peter Kollar
Aidan Coffey
Tibor Liptaj
Alois Cizek
Josef Jampilek
author_sort Tomas Gonec
title N-Alkoxyphenylhydroxynaphthalenecarboxamides and Their Antimycobacterial Activity
title_short N-Alkoxyphenylhydroxynaphthalenecarboxamides and Their Antimycobacterial Activity
title_full N-Alkoxyphenylhydroxynaphthalenecarboxamides and Their Antimycobacterial Activity
title_fullStr N-Alkoxyphenylhydroxynaphthalenecarboxamides and Their Antimycobacterial Activity
title_full_unstemmed N-Alkoxyphenylhydroxynaphthalenecarboxamides and Their Antimycobacterial Activity
title_sort n-alkoxyphenylhydroxynaphthalenecarboxamides and their antimycobacterial activity
publisher MDPI AG
series Molecules
issn 1420-3049
publishDate 2016-08-01
description A series of nineteen N-(alkoxyphenyl)-2-hydroxynaphthalene-1-carboxamides and a series of their nineteen positional isomers N-(alkoxyphenyl)-1-hydroxynaphthalene-2-carboxamides were prepared and characterized. Primary in vitro screening of all the synthesized compounds was performed against Mycobacterium tuberculosis H37Ra, M. kansasii and M. smegmatis. Screening of the cytotoxicity of the compounds was performed using human monocytic leukemia THP-1 cells. Some of the tested compounds showed antimycobacterial activity comparable with or higher than that of rifampicin. For example, 2-hydroxy-N-(4-propoxyphenyl)-naphthalene-1-carboxamide showed the highest activity (MIC = 12 µM) against M. tuberculosis with insignificant cytotoxicity. N-[3-(But-2-yloxy)phenyl]- and N-[4-(but-2-yloxy)phenyl]-2-hydroxy-naphthalene-1-carboxamide demonstrated high activity against all tested mycobacterial strains and insignificant cytotoxicity. N-(Alkoxyphenyl)-1-hydroxynaphthalene-2-carboxamides demonstrated rather high effect against M. smegmatis and M. kansasii and strong antiproliferative effect against the human THP-1 cell line. Lipophilicity was found as the main physicochemical parameter influencing the activity. A significant decrease of mycobacterial cell metabolism (viability of M. tuberculosis H37Ra) was observed using MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide) assay. Structure-activity relationships are discussed.
topic hydroxynaphthalenecarboxamides
in vitro antimycobacterial activity
MTT assay
lipophilicity
structure-activity relationships
url http://www.mdpi.com/1420-3049/21/8/1068
work_keys_str_mv AT tomasgonec nalkoxyphenylhydroxynaphthalenecarboxamidesandtheirantimycobacterialactivity
AT sarkapospisilova nalkoxyphenylhydroxynaphthalenecarboxamidesandtheirantimycobacterialactivity
AT terezakauerova nalkoxyphenylhydroxynaphthalenecarboxamidesandtheirantimycobacterialactivity
AT jirikos nalkoxyphenylhydroxynaphthalenecarboxamidesandtheirantimycobacterialactivity
AT janadohanosova nalkoxyphenylhydroxynaphthalenecarboxamidesandtheirantimycobacterialactivity
AT michaloravec nalkoxyphenylhydroxynaphthalenecarboxamidesandtheirantimycobacterialactivity
AT peterkollar nalkoxyphenylhydroxynaphthalenecarboxamidesandtheirantimycobacterialactivity
AT aidancoffey nalkoxyphenylhydroxynaphthalenecarboxamidesandtheirantimycobacterialactivity
AT tiborliptaj nalkoxyphenylhydroxynaphthalenecarboxamidesandtheirantimycobacterialactivity
AT aloiscizek nalkoxyphenylhydroxynaphthalenecarboxamidesandtheirantimycobacterialactivity
AT josefjampilek nalkoxyphenylhydroxynaphthalenecarboxamidesandtheirantimycobacterialactivity
_version_ 1725679826222710784